Possible immunological effects of psychotropic medication (Q40888131)

24 September 2017

1 reference

title

Possible immunological effects of psychotropic medication (English)

1 reference

24 September 2017

1 reference

Surman OS

1

1 reference

24 September 2017

1 March 1993

1 reference

24 September 2017

1 reference

24 September 2017

34

1 reference

24 September 2017

2

1 reference

24 September 2017

139-143

1 reference

Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Reduction of immune function in life stress and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Psychological Depression and 17-Year Risk of Death from Cancer1

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Psychoneuroimmunology. Implications for oncology?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Depression, the immune system, and health and illness. Findings in search of meaning

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Psychosomatic aspects of liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Lithium: a Modulator of Cyclic AMP-Dependent Events in Lymphocytes?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

The Use of Lithium Carbonate to Reduce Infection and Leukopenia during Systemic Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Suppression of natural killer cell activity by FG 7142, a benzodiazepine receptor "inverse agonist"

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Suppression of cytotoxic T lymphocyte (CTL) activity by FG 7142, a benzodiazepine receptor ‘inverse agonist’

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

Psychopharmacology and neuropsychiatric syndromes in organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971904-0

7 January 2021

10.1016/S0033-3182(93)71904-0

Identifiers

DOI

0 references

PubMed ID

8456156

1 reference

PubMed ID

8456156